Base Year
Historical Year
Forecast Year
The global stem cell assay market size was valued at USD 6.4 billion in 2023, with Europe holding a significant market share. The market is driven by the rising technological innovations in the field of stem cell assays. It is expected to grow at a CAGR of 13.18% during the forecast period of 2024-2032, with the values likely to attain USD 19.4 billion by 2032.
Stem cell assays are laboratory tests that are used to evaluate the behavior or function of stem cells. In Europe, they are widely utilized in clinical and research settings to obtain data on stem cell differentiation, viability, and proliferation, among others. These assays are increasingly employed in cancer research and regenerative medicine to find potential treatments for various diseases. The rising prevalence of chronic conditions including diabetes, cardiovascular diseases, and neurodegenerative disorders is expected to drive the Europe stem cell assay market growth in the coming years.
The market is significantly impacted by the rising aging population. On January 1, 2023, it was estimated that more than one-fifth of the population of the European Union was aged 65 years and above, with the median age reaching 44.5 yea rs. This growing size of the aging population in Europe reflects the need for novel therapeutic solutions, including those developed through stem cell research, which is likely to drive the market demand in the forecast period.
The rising integration of advanced and automated cell counting methods to assess stem cell viability is leading to a reduction in analyst-dependent variability and the analytical time in research labs and manufacturing facilities . This is anticipated to propel the Europe stem cell assay market demand. Additionally, these rising technological advancements in the field of stem cell assays such as high-throughput screening technologies are likely to boost efficiency and improve the accuracy of stem cell research and testing, thereby supporting market growth.
In Europe, the rising emphasis for stem cell research coupled with the presence of an established research infrastructure in the region is accelerating market growth. For instance, in June 2023, the University of Cambridge launched a project involving stem cell-based human embryo models in the United Kingdom. Such stem cell-based research activities are likely to augment the demand for various types of stem cell assays to understand stem cell biology and consequently develop stem cell therapies, ultimately elevating the market value.
The market report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Cell Type | Adult Stem Cells, Human Embryonic Stem Cells, Pluripotent |
| Type | Viability/Cytotoxicity Assays, Isolation & Purification Assays, Cell Identification Assays, Proliferation Assays, Differentiation Assays, Function Assays, Apoptosis Assays, Others |
| Product & Service | Flow Cytometers, Cell Imaging & Analysis Systems, Microelectrode Arrays, Automated Cell Counters, Kits |
| Treatment | Allogeneic Stem Cell Therapy, Autologous St |
| Application | Regenerative Medicine & Therapy Development, Drug Discovery & Development, Clinical Research, Others |
| End User | Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others |
| Countries | United Kingdom, Germany, France, Italy, Others |
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Cell Type |
|
| Breakup by Type |
|
| Breakup by Product & Service |
|
| Breakup by Treatment |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Europe Stem Cell Assay Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The Europe stem cell assay market is expected to be driven by the rising demand for the global stem cell assay market, which is anticipated to grow at a CAGR of 13.18% during the forecast period of 2024-2032 and is likely to reach a market value of USD 19.4 billion by 2032.
The rising application of stem cell assays in cancer research and regenerative medicine to find potential treatments for various chronic conditions is fuelling the demand for the market.
One of the significant trends in the market is the increased stem cell-based research activities which are likely to augment the demand for various types of stem cell assays. For instance, in June 2023, the University of Cambridge launched a project involving stem cell-based human embryo models in the United Kingdom.
The market breakup by cell type includes adult stem cells, human embryonic stem cells, and pluripotent.
By type, the market is divided into viability/cytotoxicity assays, isolation and purification assays, cell identification assays, proliferation assays, differentiation assays, function assays, and apoptosis assays, among others.
Based on the product and services, the market is segmented into flow cytometers, cell imaging and analysis systems, microelectrode arrays, automated cell counters, and kits.
Treatments available in the market include allogeneic stem cell therapy, autologous stem cell therapy, and syngeneic stem cell therapy.
Major applications include regenerative medicine and therapy development, drug discovery and development, as well as clinical research, among others.
End users of the market are biopharmaceutical and biotechnology companies, along with academic and research institutes, among others.
The market segmentation by countries includes the United Kingdom, Germany, France, and Italy, among others.
The key players in the market are Thermo Fisher Scientific, PerkinElmer, Stemcell Technologies, Merck, Bio-Rad Laboratories, Agilent Technologies, Promega, Bio-Techne, and Cell Biolabs.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share